Annual CFI
$105.95 M
+$151.83 M+330.91%
December 31, 2023
Summary
- As of February 7, 2025, STOK annual cash flow from investing activities is $105.95 million, with the most recent change of +$151.83 million (+330.91%) on December 31, 2023.
- During the last 3 years, STOK annual CFI has risen by +$107.00 million (+10190.10%).
- STOK annual CFI is now at all-time high.
Performance
STOK Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$30.00 M
+$58.27 M+66.01%
September 30, 2024
Summary
- As of February 7, 2025, STOK quarterly cash flow from investing activities is -$30.00 million, with the most recent change of +$58.27 million (+66.01%) on September 30, 2024.
- Over the past year, STOK quarterly CFI has dropped by -$44.62 million (-305.27%).
- STOK quarterly CFI is now -144.61% below its all-time high of $67.26 million, reached on September 30, 2022.
Performance
STOK Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$93.52 M
-$44.62 M-91.25%
September 30, 2024
Summary
- As of February 7, 2025, STOK TTM cash flow from investing activities is -$93.52 million, with the most recent change of -$44.62 million (-91.25%) on September 30, 2024.
- Over the past year, STOK TTM CFI has dropped by -$207.19 million (-182.28%).
- STOK TTM CFI is now -156.23% below its all-time high of $166.31 million, reached on June 30, 2023.
Performance
STOK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
STOK Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +330.9% | -305.3% | -182.3% |
| 3 y3 years | +10000.0% | -305.3% | -182.3% |
| 5 y5 years | +10000.0% | -305.3% | -182.3% |
STOK Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +238.6% | -144.6% | +77.9% | -156.2% | +55.9% |
| 5 y | 5-year | at high | +238.6% | -144.6% | +77.9% | -156.2% | +55.9% |
| alltime | all time | at high | +238.6% | -144.6% | +77.9% | -156.2% | +55.9% |
Stoke Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$30.00 M(-66.0%) | -$93.52 M(+91.2%) |
| Jun 2024 | - | -$88.28 M(-983.8%) | -$48.90 M(-177.8%) |
| Mar 2024 | - | $9.99 M(-32.4%) | $62.85 M(-40.7%) |
| Dec 2023 | $105.95 M(-330.9%) | $14.77 M(+1.1%) | $105.95 M(-6.8%) |
| Sep 2023 | - | $14.62 M(-37.7%) | $113.67 M(-31.7%) |
| Jun 2023 | - | $23.47 M(-55.8%) | $166.31 M(+16.3%) |
| Mar 2023 | - | $53.09 M(+136.0%) | $142.99 M(-411.6%) |
| Dec 2022 | -$45.88 M(-40.0%) | $22.49 M(-66.6%) | -$45.88 M(-18.9%) |
| Sep 2022 | - | $67.26 M(>+9900.0%) | -$56.58 M(-56.2%) |
| Jun 2022 | - | $146.00 K(-100.1%) | -$129.10 M(-39.1%) |
| Mar 2022 | - | -$135.78 M(-1251.0%) | -$212.00 M(+177.4%) |
| Dec 2021 | -$76.43 M | $11.80 M(-324.1%) | -$76.43 M(-13.5%) |
| Sep 2021 | - | -$5.26 M(-93.6%) | -$88.31 M(+6.0%) |
| Jun 2021 | - | -$82.75 M(>+9900.0%) | -$83.32 M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$204.00 K(+126.7%) | -$644.00 K(-38.7%) |
| Dec 2020 | -$1.05 M(-35.7%) | -$90.00 K(-66.5%) | -$1.05 M(-31.3%) |
| Sep 2020 | - | -$269.00 K(+232.1%) | -$1.53 M(-17.0%) |
| Jun 2020 | - | -$81.00 K(-86.7%) | -$1.84 M(-14.4%) |
| Mar 2020 | - | -$610.00 K(+7.2%) | -$2.15 M(+31.8%) |
| Dec 2019 | -$1.63 M(+76.6%) | -$569.00 K(-2.4%) | -$1.63 M(+42.3%) |
| Sep 2019 | - | -$583.00 K(+48.7%) | -$1.15 M(+6.2%) |
| Jun 2019 | - | -$392.00 K(+335.6%) | -$1.08 M(+9.3%) |
| Mar 2019 | - | -$90.00 K(+8.4%) | -$989.00 K(+6.9%) |
| Dec 2018 | -$925.00 K(+718.6%) | -$83.00 K(-83.9%) | -$925.00 K(+9.9%) |
| Sep 2018 | - | -$516.00 K(+72.0%) | -$842.00 K(+158.3%) |
| Jun 2018 | - | -$300.00 K(+1053.8%) | -$326.00 K(+1153.8%) |
| Mar 2018 | - | -$26.00 K | -$26.00 K |
| Dec 2017 | -$113.00 K | - | - |
FAQ
- What is Stoke Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Stoke Therapeutics?
- What is Stoke Therapeutics annual CFI year-on-year change?
- What is Stoke Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly CFI year-on-year change?
- What is Stoke Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Stoke Therapeutics?
- What is Stoke Therapeutics TTM CFI year-on-year change?
What is Stoke Therapeutics annual cash flow from investing activities?
The current annual CFI of STOK is $105.95 M
What is the all time high annual CFI for Stoke Therapeutics?
Stoke Therapeutics all-time high annual cash flow from investing activities is $105.95 M
What is Stoke Therapeutics annual CFI year-on-year change?
Over the past year, STOK annual cash flow from investing activities has changed by +$151.83 M (+330.91%)
What is Stoke Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of STOK is -$30.00 M
What is the all time high quarterly CFI for Stoke Therapeutics?
Stoke Therapeutics all-time high quarterly cash flow from investing activities is $67.26 M
What is Stoke Therapeutics quarterly CFI year-on-year change?
Over the past year, STOK quarterly cash flow from investing activities has changed by -$44.62 M (-305.27%)
What is Stoke Therapeutics TTM cash flow from investing activities?
The current TTM CFI of STOK is -$93.52 M
What is the all time high TTM CFI for Stoke Therapeutics?
Stoke Therapeutics all-time high TTM cash flow from investing activities is $166.31 M
What is Stoke Therapeutics TTM CFI year-on-year change?
Over the past year, STOK TTM cash flow from investing activities has changed by -$207.19 M (-182.28%)